about
Controlled Payload Release by Magnetic Field Triggered Neural Stem Cell Destruction for Malignant Glioma TreatmentExceptional aggressiveness of cerebral cavernous malformation disease associated with PDCD10 mutationsDepletion of myeloid-derived suppressor cells during interleukin-12 immunogene therapy does not confer a survival advantage in experimental malignant glioma.Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain tumors.Blood-brain barrier permeable gold nanoparticles: an efficient delivery platform for enhanced malignant glioma therapy and imagingBleeding and infection with external ventricular drainage: a systematic review in comparison with adjudicated adverse events in the ongoing Clot Lysis Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III (CLEAR-III IHV) trialDynamic permeability and quantitative susceptibility: related imaging biomarkers in cerebral cavernous malformationsβIII-Tubulin Regulates Breast Cancer Metastases to the Brain.A Genetically Modified Adenoviral Vector with a Phage Display-Derived Peptide Incorporated into Fiber Fibritin Chimera Prolongs Survival in Experimental Glioma.Dendritic Cell-Based Vaccines that Utilize Myeloid Rather than Plasmacytoid Cells Offer a Superior Survival Advantage in Malignant Glioma.Neural Stem Cells Secreting Anti-HER2 Antibody Improve Survival in a Preclinical Model of HER2 Overexpressing Breast Cancer Brain Metastases.Vascular permeability in cerebral cavernous malformations.Rotating magnetic field induced oscillation of magnetic particles for in vivo mechanical destruction of malignant glioma.Naltrexone reduction of long-term smoking cessation weight gain in women but not men: a randomized controlled trial.Single dose GLP toxicity and biodistribution study of a conditionally replicative adenovirus vector, CRAd-S-pk7, administered by intracerebral injection to Syrian hamsters.Peripheral plasma vitamin D and non-HDL cholesterol reflect the severity of cerebral cavernous malformation disease.Quantitative Susceptibility Mapping in Cerebral Cavernous Malformations: Clinical Correlations.Effects of the opioid receptor antagonist naltrexone on smoking and related behaviors in smokers preparing to quit: a randomized controlled trialInhibition of MMP14 potentiates the therapeutic effect of temozolomide and radiation in gliomas.Intranasal Oncolytic Virotherapy with CXCR4-Enhanced Stem Cells Extends Survival in Mouse Model of Glioma.Intranasal delivery of mesenchymal stem cells significantly extends survival of irradiated mice with experimental brain tumorsMesenchymal stem cell carriers enhance antitumor efficacy of oncolytic adenoviruses in an immunocompetent mouse model.Dedifferentiation of Glioma Cells to Glioma Stem-like Cells By Therapeutic Stress-induced HIF Signaling in the Recurrent GBM Model.Dynamic In Vivo SPECT Imaging of Neural Stem Cells Functionalized with Radiolabeled Nanoparticles for Tracking of Glioblastoma.B-Cell Depletion Reduces the Maturation of Cerebral Cavernous Malformations in Murine Models.Demographic Risk Factors for Vascular Lesions as Etiology of Intraventricular Hemorrhage in Prospectively Screened Cases.CSF inflammatory response after intraventricular hemorrhage.CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells.Intratumoral oncolytic adenoviral treatment modulates the glioma microenvironment and facilitates systemic tumor-antigen-specific T cell therapy.Survival and complications of stereotactic radiosurgery: A systematic review of stereotactic radiosurgery for newly diagnosed and recurrent high-grade gliomas.RhoA Kinase Inhibition With Fasudil Versus Simvastatin in Murine Models of Cerebral Cavernous Malformations.Anti-GITR therapy promotes immunity against malignant glioma in a murine model.Cell-Penetrating Peptide-Modified Gold Nanoparticles for the Delivery of Doxorubicin to Brain Metastatic Breast Cancer.Geographically Derived Socioeconomic Factors to Improve Risk Prediction in Patients Having Aortic Valve ReplacementA maximum likelihood approach to electronic health record phenotyping using positive and unlabeled patients
P50
Q28552160-77A9B048-BF50-4130-9DEA-6151523004DAQ30389638-C67EB124-8E49-48ED-AB5F-36108A721459Q33670136-95066844-FACA-4C02-94B4-CF158BA00217Q34276759-BD6D3414-5EF8-45E1-8CB8-5237D662CDC5Q34714550-C8D243C6-10B1-4D97-B325-D4F086F7E450Q35096734-B92B7ACD-F23D-412D-BBA9-E0E694C144F3Q35151828-AA7748CA-912E-4F86-8913-F71901D5E89FQ35587344-7BFDED9F-8E1A-415B-82A8-4FBC08924A9CQ35658592-BF866D96-1F6E-4B40-B587-E2CAF476D6A1Q35763478-56F5802B-30CE-4F55-BF81-1E0DAB1B57BEQ36083446-2DFB822F-FC8B-449C-99B2-4D8ADA0C954AQ36267403-473F9373-8E84-4655-A4B0-A7E3CE0A1F8BQ36494770-56D0803D-2371-474D-82CE-3879141C0F83Q36774139-9BEE6DBC-067D-4AFC-83B3-407F0C8EA871Q36904198-FDE82D72-0344-44B2-8AF1-146F5C97AD92Q37050968-92367AD5-2AF6-43FA-A94D-7234D560D37AQ37099099-BE42AE5C-C9E5-4F6E-BB20-39B969030D21Q37179217-BA9850F1-FDF4-477A-B815-7030F36F5824Q37236243-80BD4D20-6A08-4AA0-855E-21324CB67AD3Q37274612-1C5522F3-75AD-4BCF-9604-43E4E25D3FBDQ38648551-7C081CBA-9F49-4729-83E2-2AB071C29678Q38702903-8C4DD014-C36A-4ECB-ACD2-766360D09BD2Q38739262-E2D15C0C-38EA-410A-82B9-FAE158F8F6C7Q38819741-5144BA18-2BDE-4B4B-80F9-DBAB336F0F1DQ38880171-127368B8-96A0-4A26-BB97-7F1445A5BB68Q38937219-3A2827AC-A3B8-4581-A76C-A0964045E141Q40059686-BAF21D06-40BA-4472-81CA-0570FE306843Q40619963-31FA0F2D-E35C-4234-877B-A7A1A4B6033CQ40982444-32AA783F-37C3-41DB-AA8E-5C6858DC5154Q47128299-009540B2-9184-4204-AD88-E9412C75EB00Q48419319-661B63F7-D304-45BD-902D-4DA484B4F652Q48480477-9DD34619-6C27-4889-A96E-2A7383C92906Q48742590-B031FE08-1E7B-46E2-A788-09C1A187DCDBQ58550153-1ED9C054-AB41-4E66-BD3F-EB539A44F03AQ91269742-3818A6F8-CC23-4ED8-AE8B-3499A2ADF5A5
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Lingjiao Zhang
@en
Lingjiao Zhang
@nl
type
label
Lingjiao Zhang
@en
Lingjiao Zhang
@nl
prefLabel
Lingjiao Zhang
@en
Lingjiao Zhang
@nl
P31
P496
0000-0003-0700-4584